CEUAX | SCIIX | CEUAX / SCIIX | |
Total Expense Ratio | 0.85 | 1.30 | 65% |
Annual Report Gross Expense Ratio | 0.85 | 1.48 | 57% |
Fund Existence | 24 years | 30 years | - |
Gain YTD | 14.456 | 6.747 | 214% |
Front Load | 4% | 6% | 64% |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 134B | 338M | 39,645% |
Annual Yield % from dividends | 0.70 | 0.00 | - |
Returns for 1 year | 10.54 | -19.46 | -54% |
Returns for 3 years | 27.27 | -13.06 | -209% |
Returns for 5 years | 13.36 | -23.27 | -57% |
Returns for 10 years | 36.79 | -31.05 | -118% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RICCX | 63.93 | 0.28 | +0.44% |
American Funds Invmt Co of Amer R3 | |||
TGVAX | 31.01 | 0.12 | +0.39% |
Thornburg International Equity A | |||
ETAHX | 34.79 | 0.13 | +0.38% |
Eventide Healthcare & Life Sciences A | |||
QCGDX | 14.66 | 0.01 | +0.07% |
Quantified Common Ground Investor | |||
VALSX | 36.73 | N/A | N/A |
Value Line Select Growth Fund |